Canon Closes Offices in Japan rtmworld

Canon Closes Offices in Japan to Fight COVID-19

Canon Closes Offices in Japan to Fight COVID-19

Canon Closes Offices in Japan rtmworldThe novel coronavirus (COVID-19) continues to rapidly spread throughout Tokyo and other large urban areas. In response, Canon Inc. (Canon) temporarily suspend operations on Tuesday, April 7 and will not reopen until Wednesday, May 6.

Canon claims its highest priorities under this situation are to protect the health of its employees and their families, neighboring families and businesses, as well as customers and business partners, and to help prevent the spread of the novel coronavirus.

■ Offices to be closed

April 7 (Tuesday) – May 6 (Wednesday)

  • Company Headquarters: 30-2, Shimomaruko 3-chome, Ohta-ku, Tokyo 146-8501, Japan
  • Kawasaki Office: 70-1 Yanagicho, Saiwai-ku, Kawasaki, Kanagawa 212-8602, Japan
  • Kosugi Office: 9-1, Imaikami-cho, Nakahara-ku, Kawasaki, Kanagawa 211-8501, Japan
  • Tamagawa Office: 16-1, Shimonoge 3-chome, Takatsu-ku, Kawasaki, Kanagawa 213-8512, Japan
  • Yako office: 451, Tsukagoshi 3-chome, Saiwai-ku, Kawasaki, Kanagawa 212-8530, Japan

April 8 (Wed.) – May 6 (Wed.)

  • Hiratsuka Plant: 22-5, Tamura 9-chome, Hiratsuka, Kanagawa 254-0013, Japan
  • Ayase Plant: 2596 Yoshioka, Ayase, Kanagawa 252-1124, Japan

This temporary suspension of operations has been enacted for reasons of health and safety, and to help prevent the spread of the novel coronavirus. Canon claims there have been no infections among employees at any of the above offices.

In an official statement, Canon also said: “We sincerely apologize for any difficulties caused to our customers and business partners as a result of this decision, and greatly appreciate your understanding.”

Canon will continue to respond to the changing situation, maintaining as our highest priorities the protection the health of our employees and their families, neighboring families and businesses, customers and business partners, and to help prevent the spread of the novel coronavirus. They will review and revise our response as the situation evolves.


Related:

0 replies

Leave a Comment

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *